GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » MedTech Acquisition Corp (NAS:MTACW) » Definitions » PensionAndRetirementBenefit

Switch to:

MedTech Acquisition (MedTech Acquisition) PensionAndRetirementBenefit : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MedTech Acquisition PensionAndRetirementBenefit?

MedTech Acquisition's PensionAndRetirementBenefit for the quarter that ended in Jun. 2023 was $0.00 Mil.

MedTech Acquisition PensionAndRetirementBenefit Historical Data

The historical data trend for MedTech Acquisition's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedTech Acquisition PensionAndRetirementBenefit Chart

MedTech Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

PensionAndRetirementBenefit

-

-

-

MedTech Acquisition Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
PensionAndRetirementBenefit	Get a 7-Day Free Trial							-	-	-	-	-

MedTech Acquisition PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

MedTech Acquisition (MedTech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » MedTech Acquisition Corp (NAS:MTACW) » Definitions » PensionAndRetirementBenefit

Comparable Companies

Traded in Other Exchanges

N/A

Address

48 Maple Avenue, Greenwich, CT, USA, 06830

Website

MedTech Acquisition Corp is a blank check company.

MedTech Acquisition (MedTech Acquisition) Headlines

From GuruFocus

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD� Method with the TriNav� Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

By Business Wire Business Wire • 06-12-2023

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

By Value_Insider Value_Insider • 12-08-2022

MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering

By Marketwired Marketwired • 12-23-2020

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

By PRNewswire PRNewswire • 08-19-2021

MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021

By Marketwired Marketwired • 02-06-2021

Memic Announces Adoption of Hominis� Surgical System at Three Leading U.S. Hospitals in Q4 2021

By PRNewswire PRNewswire • 01-06-2022

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

By PRNewswire PRNewswire • 08-13-2021

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

By GlobeNewswire GlobeNewswire • 12-08-2022

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

By Business Wire Business Wire • 02-21-2023

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

By Business Wire • 08-02-2023

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.